对预测COVID-19患者预后的六个营养评分进行比较分析
Shangpu Zou1, Pengcheng Lin1, Xiaoyu Chen2
1The Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Frontiers in nutrition
|December 13, 2024
概括
营养风险查对COVID-19患者至关重要. 2002年营养风险查 (NRS-2002) 评分和修改后的NUTRIC评分分别有效预测所有COVID-19患者和ICU患者的预后.
科学领域:
- 医疗营养治疗 治疗 治疗
- 传染病流行病学 传染病流行病学
- 关键护理医学 关键护理医学
背景情况:
- 由于各种查工具,评估COVID-19患者的营养风险是复杂的.
- 这项研究解决了在COVID-19患者中识别营养风险的挑战.
研究的目的:
- 评估六个营养分数在预测COVID-19患者预后方面的有效性.
- 为了比较NRS-2002,NUTRIC,mNUTRIC,PNI,CONUT和TCBI的预测精度.
主要方法:
- 从506名COVID-19患者 (2022年12月 - 2023年2月) 的临床数据的回顾性分析.
- 患者被分为普通和重症监护室 (ICU) 组,并根据生存状态进一步分层.
- 使用多变量分析和接收器操作特征 (ROC) 曲线来评估预测器的有效性.
主要成果:
- 在所有COVID-19患者中,NRS-2002和TCBI是显著的预测因素;在ICU患者中,APACHE II和mNUTRIC是显著的预测因素.
- 在所有患者中,NRS-2002显示出更高的AUC (0.687),而在ICU患者中,mNUTRIC显示出更高的AUC (0.884).
- 在所有患者中,NRS-2002提供了最大的净益;在ICU患者中,NUTRIC和mNUTRIC提供了最大的净益.
结论:
- 在COVID-19患者中,营养不良很普遍.
- mNUTRIC评分和NRS-2002是COVID-19患者的有效预后工具,特别是在ICU环境中.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
150
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
150
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328